Publication | Closed Access

Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism

RheumatologyAutoimmune DiseaseThyroid DiseasePathologySapho SyndromeThyroid DisordersProlonged Clinical RemissionDermatologyThyroid HormoneEndocrinologyMedicineThyroid Hormonal RequirementsEndocrine Disease